Extracellular vesicles related to familial hypercholesterolemia

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Extracellular Vesicle Research

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder leading to high LDL cholesterol.
• Cardiovascular complications are common in FH patients.
• Extracellular vesicles (EVs) are implicated in various physiological and pathological processes.

Purpose of the Study:

• To compare extracellular vesicle (EV) profiles in familial hypercholesterolemia (FH) genetic variant carriers versus non-FH family members.
• To investigate the association of specific EV subtypes with FH genetic status and lipid levels.

Main Methods:

• Evaluated Annexin V-positive EVs (PS+-EVs), cardiomyocyte-derived EVs (CardioEVs), endothelial cell-derived EVs (EEVs), platelet-derived EVs (PEVs), and tissue factor-expressing EVs (TFEVs).
• Compared EV counts between FH genetic variant carriers (n=16) and non-FH controls (n=16).
• Analyzed EV levels in relation to statin use and LDL cholesterol (LDL-c).

Main Results:

• Increased numbers of PS+-EVs, CardioEVs, EEVs, and TFEVs were found in FH genetic variant carriers.
• FH patients not using statins showed higher counts of these EVs compared to non-FH patients without statins.
• Elevated EV counts were significantly correlated with higher LDL-c levels.

Conclusions:

• Extracellular vesicles (EVs) are associated with familial hypercholesterolemia (FH).
• The cellular origins of these EVs may relate to cardiovascular complications seen in FH.
• EVs could serve as potential biomarkers for FH and its associated cardiovascular risks.